{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:07:20Z","timestamp":1762506440475},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,10,2]],"date-time":"2014-10-02T00:00:00Z","timestamp":1412208000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s11239-014-1139-5","type":"journal-article","created":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T09:41:25Z","timestamp":1412156485000},"page":"499-507","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Safety and efficacy of in-hospital clopidogrel-to-prasugrel switching in patients with acute coronary syndrome. An analysis from the \u2018real world\u2019"],"prefix":"10.1007","volume":"39","author":[{"given":"Manuel","family":"Almendro-Delia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Blanco Ponce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Gomez-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Gonzalez-Matos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Lobo-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Auxiliadora","family":"Caballero-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Hidalgo-Urbano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jose","family":"Cruz-Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Garcia-Rubira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,2]]},"reference":[{"key":"1139_CR1","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"CW Hamm","year":"2011","unstructured":"Hamm CW, Bassand JP, Agewall S et al (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 32:2999\u20133054","journal-title":"Eur Heart J"},{"key":"1139_CR2","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","volume":"33","author":"PG Steg","year":"2012","unstructured":"Steg PG, James SK, Atar D et al (2012) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33:2569\u20132619","journal-title":"Eur Heart J"},{"key":"1139_CR3","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"SD Wiviott","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH et al (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357:2001\u20132015","journal-title":"N Engl J Med"},{"key":"1139_CR4","unstructured":"Bueno H, Storey RF, Danchin N, et al (2012) Current regional differences in the use of antiplatelet drugs for the treatment of acute coronary syndromes: results from the EPICOR study. Eur Heart J 33(suppl. 1):311. Abstract"},{"key":"1139_CR5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/HPC.0b013e3181fe9817","volume":"9","author":"J Marchini","year":"2010","unstructured":"Marchini J, Morrow D, Resnic F et al (2010) An Algorithm for use of prasugrel (effient) in patients undergoing cardiac catheterization and percutaneous coronary intervention. Crit Pathw Cardiol 9:192\u2013198","journal-title":"Crit Pathw Cardiol"},{"key":"1139_CR6","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1016\/j.ijcard.2013.08.007","volume":"168","author":"D Alexopoulos","year":"2013","unstructured":"Alexopoulos D, Goudevenos JA, Xanthopoulou I et al (2013) Implementation of contemporary oral antiplatelet treatment guidelines in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a report from the GReek AntiPlatelet rEgistry (GRAPE). Int J Cardiol 168:5329\u20135335","journal-title":"Int J Cardiol"},{"key":"1139_CR7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1160\/TH09-07-0482","volume":"103","author":"G Montalescot","year":"2010","unstructured":"Montalescot G, Sideris G, Cohen R et al (2010) Prasugrel compared with high-dose clopidogrel in acute coronary syndrome. The randomised, double-blind ACAPULCO study. Thromb Haemost 103:213\u2013223","journal-title":"Thromb Haemost"},{"key":"1139_CR8","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jacc.2010.02.072","volume":"56","author":"DJ Angiolillo","year":"2010","unstructured":"Angiolillo DJ, Saucedo JF, Deraad R et al (2010) Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (SWitching Anti Platelet) study. J Am Coll Cardiol 56:1017\u20131023","journal-title":"J Am Coll Cardiol"},{"key":"1139_CR9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1056\/NEJMc1213509","volume":"368","author":"MT Roe","year":"2013","unstructured":"Roe MT, Armstrong PW, Fox KA et al (2013) (2013) Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med 368:188\u2013189","journal-title":"N Engl J Med"},{"key":"1139_CR10","unstructured":"Schiele F, Puymirat E, Lorgis L, et al (2012) Switch and non switch in P2Y12 inhibition: the real life use of clopidogrel and prasugrel in patients with acute myocardial infarction. Insights from the FAST MI 2010 registry. Eur Heart J 33(Suppl. 1):204. Abstract"},{"key":"1139_CR11","unstructured":"Bagai A, Peterson ED, Honeycutt E, et al (2012) In-Hospital switching of ADP receptor inhibitors in myocardial infarction patients treated with percutaneous coronary intervention: Insights from the TRANSLATE-ACS Study. Circulation 126:A15573. Abstract"},{"key":"1139_CR12","doi-asserted-by":"crossref","unstructured":"Parodi G, De Luca G, Bellandi B, et al (2014) Switching from clopidogrel to prasugrel in patients undergoing coronary stent implantation. J Thromb Thrombolysis. doi: 10.1007\/s11239-013-1040-7 .[in press]","DOI":"10.1007\/s11239-013-1040-7"},{"key":"1139_CR13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.CIR.76.1.142","volume":"76","author":"JH Chesebro","year":"1987","unstructured":"Chesebro JH, Knatterud G, Roberts R et al (1987) Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 76:15\u2013142","journal-title":"Circulation"},{"key":"1139_CR14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCOUTCOMES.111.000060","volume":"6","author":"A Sandhu","year":"2013","unstructured":"Sandhu A, Seth M, Dixon S et al (2013) Contemporary use of prasugrel in clinical practice: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. Circ Cardiovasc Qual Outcomes 6:293\u2013298","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"1139_CR15","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1161\/CIRCULATIONAHA.107.740324","volume":"116","author":"SD Wiviott","year":"2007","unstructured":"Wiviott SD, Trenk D, Frelinger AL et al (2007) Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial. Circulation 116:2923\u20132932","journal-title":"Circulation"},{"key":"1139_CR16","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.amjcard.2012.11.058","volume":"111","author":"JP Loh","year":"2013","unstructured":"Loh JP, Pendyala LK, Kitabata H et al (2013) Safety of reloading prasugrel in addition to clopidogrel loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Am J Cardiol 111:841\u2013845","journal-title":"Am J Cardiol"},{"key":"1139_CR17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1161\/CIRCINTERVENTIONS.112.000063","volume":"6","author":"JG Diodati","year":"2013","unstructured":"Diodati JG, Saucedo JF, French JK et al (2013) Effect on platelet reactivity from a prasugrel loading dose after clopidogrel loading dose compared with a prasugrel loading dose alone: transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients (TRIPLET): a randomized controlled trial. Circ Cardiovasc Interv 6:567\u2013574","journal-title":"Circ Cardiovasc Interv"},{"key":"1139_CR18","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1016\/j.ijcard.2013.06.078","volume":"168","author":"N Fournier","year":"2013","unstructured":"Fournier N, Toesca R, Bessereau J et al (2013) Ticagrelor or prasugrel for pre-hospital protocols in STEMI? Int J Cardiol 168:4566\u20134567","journal-title":"Int J Cardiol"},{"issue":"1","key":"1139_CR19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ahj.2013.10.010","volume":"167","author":"D Alexopoulos","year":"2014","unstructured":"Alexopoulos D, Xanthopoulou I, Deftereos S et al (2014) In-hospital switching of oral P2Y12 inhibitor treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prevalence, predictors and short-term outcome. Am Heart J 167(1):68\u201376","journal-title":"Am Heart J"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-014-1139-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-014-1139-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-014-1139-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T11:02:07Z","timestamp":1559386927000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-014-1139-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,2]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["1139"],"URL":"https:\/\/doi.org\/10.1007\/s11239-014-1139-5","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,2]]}}}